Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Pediatric Blood & Cancer|July 12, 2005
Treatment of a clinically determined lower-risk stage III non-lymphoblastic Non-Hodgkin lymphoma with less intensive therapy does not impact negatively on outcomeAsim F Belgaumi, Lobna Shalaby, Amani Al-Kofide, et al.
Pediatric Cardiology|December 16, 2015
Early Ventricular Dysfunction After Anthracycline Chemotherapy in ChildrenHala Agha, Lobna Shalaby, Wael Attia, et al.
Personalized Medicine|October 8, 2025
Tailoring pediatric vancomycin doses: achieving therapeutic levels and minimizing toxicity in oncology patientsNadeen Hossam, Dalia Makhlouf, Ahmed Elzeiny, et al.
Mycoses|September 13, 2019
Clinical features and outcome of hepatosplenic fungal infections in children with haematological malignanciesYoussef Madney, Lobna Shalaby, Mervat Elanany, et al.
Journal of Fungi (Basel, Switzerland)|August 26, 2022
COVID-19-Associated Pulmonary Fungal Infection among Pediatric Cancer Patients, a Single Center ExperienceYoussef Madney, Lobna Shalaby, Mahmoud Hammad, et al.
Personalized Medicine|July 4, 2024
Optimizing vancomycin therapeutic drug monitoring compliance in pediatric oncology: towards personalized medication managementRewan Gamal Mohamed, Rania Saber, Mohamed Ali Hussein, et al.
Antibiotics (Basel, Switzerland)|February 25, 2023
Carbapenem-Resistant Enterobacteriaceae (CRE) among Children with Cancer: Predictors of Mortality and Treatment OutcomeYoussef Madney, Shaimaa Aboubakr, Reham Khedr, et al.
Frontiers in Oncology|May 8, 2026
Gram-negative blood-stream infections and emerging antimicrobial resistance in children with acute myeloid leukemia during induction chemotherapy at Children's Cancer Hospital Egypt 57357Grace Mbatia, Reham Khedr, Leslie Lehmann, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|May 7, 2019
Treatment of immunocompromised patients with suspected invasive fungal infections: economic analysis of diagnostic-driven versus empirical strategies in Algeria and EgyptZohra Kaci, Lobna Shalaby, Sherif Kamal, et al.
Pediatric Blood & Cancer|December 30, 2025
Preemptive Versus Empirical Antifungal Therapy for High-Risk, Febrile, Neutropenic Solid Tumor Patients in an LMIC SettingOmnia Al-Qadi, Lobna Shalaby, Mervat El Anany, et al.
Pageof 4